B2UXE0 AF NFT

Adenosylcobinamide-GDP ribazoletransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeif6qveuqfrm3ttfahjyv4xzclg35sppugqv354zc42a3sh7v45emi/metadata.json
IPFS of structure file: 
bafybeigka5x3visozxpx464m2csrolx527dqetouwqwtqszhkhrtcsiu5y/AF-B2UXE0-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xc0F878C3f3E2a1874e2A6daC80d429e553DdB0D5
First NFT owner address (bech32): 
genesis1cru83slnu2scwn32dkkgp4pfu4famvx4x7nssv
Current NFT ID #71177 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
71177
Accession (UniProt):
B2UXE0
Name::
Adenosylcobinamide-GDP ribazoletransferase
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN ALASKA E43 / TYPE E3)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2UXE0 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2UXE0|COBS_CLOBA Adenosylcobinamide-GDP ribazoletransferase OS=Clostridium botulinum (strain Alaska E43 / Type E3) OX=508767 GN=cobS PE=3 SV=1 MKNLFKGLMMSLSMFTIIPMPYVEWDEDGAKNMMKCYPIIGLIVGCVWFLGYKLINYLNISIVLKSALIMIIPFIITGMLHLDGFMDVCDAILSRRDKEEKLRILKDSTTGAFSVISVIILFFIQFGAVHSFLEYNKNPYILMFLPIISRNIVAYFFITIITIKESTLGSYFTKGTNIKDKVILILELALVCILFGSILGYIGIAILLIVAVAISLCVKKCFKEFGGISGDVAGFSLVVGEIVGLFSACLFT